PSL Develops Microsphere Refiner for Formulation of Microspheres - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

PSL Develops Microsphere Refiner for Formulation of Microspheres
PSL has developed a microsphere refiner for microsphere formulation, from small scale processes to commercial production.


PSL, a manufacturer of filtration, drying and complete containment solutions, announced that it has developed a microsphere refiner for microsphere formulation. There is a high demand for microsphere production within the pharmaceutical industry. Formulation methods are usually developed by laboratory development contract organisations and research universities. The PSL microsphere refiner offers unique filtration solutions for microsphere formulation, from small scale processes to commercial production.

Microspheres are small spherical particles, typically ranging from 5 microns up to 250 microns. The particles are manufactured from various natural and synthetic materials such as polymer microspheres. The biodegradable polymer microspheres can work as miniature time-release capsules for parenteral drugs.

Suspended microspheres obtained from various microencapsulation processes require unique handling that is different from a typical filtration and drying operation. After the synthesis stage, microspheres must be washed, classified by size, filtered and dried under appropriate conditions to gain the final free-flowing injectable or inhalation microsphere product. PSL microsphere refiners have been designed to meet these criteria from washing to classifying and drying. Size classification, considered the most difficult step in microspheres production, can be achieved with PSL’s unique design, which utilises side and bottom filtration.

Microsphere processes generally involve handling large liquid volumes with a small ratio of suspended solids. Some processes would therefore require a scalping prefiltration step to reduce the liquid volume and eliminate the oversized microspheres. This can achieved with the PSL scalping filter prior to transfer into the PSL microsphere refiner. PSL stated in its press release that several projects have been completed using the company’s microsphere filtration solutions from laboratory scale to commercial production.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
33%
Breakthrough designations
11%
Protecting the supply chain
39%
Expedited reviews of drug submissions
11%
More stakeholder involvement
6%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests

Click here